IMOV
Investment Management of Virginia Portfolio holdings
AUM
$526M
1-Year Est. Return
3.23%
This Fund
S&P 500
1 Year Est. Return
-3.23%
AUM
$510M
AUM Growth
+$47.7M
(+10%)
Holding
182
Top Buys
| 1 | +$5M | |
| 2 | +$3.53M | |
| 3 | +$3.07M | |
| 4 |
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
|
+$2.72M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$2.57M |
Top Sells
| 1 | +$3.52M | |
| 2 | +$3.44M | |
| 3 | +$3M | |
| 4 |
Qualcomm
QCOM
|
+$2.9M |
| 5 |
Ligand Pharmaceuticals
LGND
|
+$2.47M |
Sector Composition
| 1 | Healthcare | 18.34% |
| 2 | Financials | 17.21% |
| 3 | Technology | 14.58% |
| 4 | Industrials | 7.87% |
| 5 | Energy | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Amgen
AMGN
$191B
| $210K | 0.04% |
+800
|
|
||
177
OmniAb
OABI
$262M
| $125K | 0.02% |
+34,710
|
|
||
178
Globalstar
GSAT
$7.61B
| $106K | 0.02% |
5,333
|
|
||
|
CIK
179
Credit Suisse Asset Management Income Fund
CIK
$141M
| $43.9K | 0.01% |
17,440
|
|
||
180
Babcock & Wilcox
BW
$1.95B
| – | – |
-99,400
|
|
||
181
Medtronic
MDT
$113B
| – | – |
-4,365
|
|
||
|
182
Ligand Pharmaceuticals
LGND
$4.15B
| – | – |
-45,964
|
|